BIOMAT Database Logo BIOMAT Database Logo

Zidovudine therapy in thrombocytopenic human immunodeficiency virus-infected children. 1991

G Lambert, and S Arpadi, and A Wiznia, and M Wong

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

G Lambert, and S Arpadi, and A Wiznia, and M Wong
Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
July 1991, The Journal of pediatrics,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children.
January 1999, European journal of pediatrics,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
February 1997, The Journal of pediatrics,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Development and significance of zidovudine resistance in children infected with human immunodeficiency virus.
July 1993, The Journal of pediatrics,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients.
June 1999, The Journal of infectious diseases,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.
March 1989, Annals of internal medicine,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
February 1994, Pediatrics,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Zidovudine therapy and left ventricular function and mass in human immunodeficiency virus-infected patients.
January 1997, Cardiology,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: successful treatment with zidovudine.
April 1991, Southern medical journal,
G Lambert, and S Arpadi, and A Wiznia, and M Wong
Zidovudine phosphorylation after short-term and long-term therapy with zidovudine in patients infected with the human immunodeficiency virus.
August 1996, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!